Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Due Dec 31, 2027National Park Service · Amount varies
This National Park Service opportunity offers Master Cooperative Agreements to participants in the Cooperative Ecosystem Studies Units (CESU) network across listed regions, supporting research, technical assistance, education, and capacity building. Only existing CESU network partners may apply, so applicants must already have joined the network. No specific award amount is provided.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityNIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIDCR (UG3/UH3) cooperative agreement funds planning and implementation of drug, biologic, device, or procedure intervention clinical trials within NIDCR's mission. A clinical trial is required. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityStimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIH SHINE (R01) opportunity supports innovative basic and early translational research in nonmalignant hematology, relevant to NIDDK, NIA, and NHLBI missions. It is intended for research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityContinuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIDCR (UH3) opportunity funds competing renewal or competitive revision of ongoing clinical trials already supported by NIDCR; a clinical trial is required. Because it continues existing NIDCR-funded trials, it is effectively limited to current grantees and not open to new projects. It is aimed at research and academic institutions; foreign organizations are not eligible. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Up to $500K
This NIDCR (UG3/UH3) cooperative agreement funds planning and implementation of behavioral and social intervention clinical trials for dental, oral, or craniofacial conditions, with a milestone-driven planning phase before transition to a full trial. A clinical trial is required. It is aimed at research and academic institutions; foreign organizations are not eligible. The maximum award is about $500,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityDevelopment of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $200K
This NIH ORIP (R21) opportunity funds research to develop, improve, and preserve animal models and related biological materials with broad applicability across multiple NIH institutes; single-disease or single-institute projects are out of scope. It is aimed at research and academic institutions; foreign organizations are not eligible. The maximum award is about $200,000.
ResearchersSchools & universitiesNarrow eligibilityDevelopment of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R61/R33) opportunity funds discovery and early evaluation of candidate biomarkers for neurological and neuromuscular disorders, requiring preliminary human-sample evaluation. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityMechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $500K
This NCI (R01) opportunity funds investigator-initiated studies on the mechanisms by which bariatric surgery affects cancer risk. It is intended for research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $500,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityFocused Technology Research and Development (R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH award funds research projects developing new technologies to advance biomedical knowledge acquisition, aimed at institutions including HBCUs, Hispanic-serving institutions, and tribal colleges, among others. Foreign organizations and their non-U.S. components are not eligible to apply. No specific dollar amount is listed, and the deadline is not imminent.
Schools & universitiesResearchersNarrow eligibilityMolecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $500K
This NIH (R01) opportunity funds development and use of molecular imaging methods to study inflammation in cancer in vivo, encouraging collaboration between cancer biologists and imaging scientists. It is intended for research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $500,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R21) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, examining underlying neurobiological and behavioral mechanisms. It targets research and academic institutions and interdisciplinary research teams, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIDCR (K22) career-transition award helps qualified dentists move from NIH intramural postdoctoral positions to extramural faculty roles, funding mentored training plus independent research. It is an individual career-development award for early-career dentist-scientists at eligible institutions; foreign organizations are not eligible. This is narrowly targeted and not suited to organizations seeking project funding. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityResearch Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
The REAP program funds small-scale research at health professional and graduate schools that haven't been major recipients of NIH support, while giving students hands-on research experience. Eligibility is limited to institutions awarding NIH-relevant degrees that received under $6 million per year in NIH support in 4 of the last 7 years — a specific financial threshold worth checking before applying. Awards go up to $375,000.
ResearchersSchools & universitiesNarrow eligibilityIntegration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $500K
An NIH/NCI research project grant (R01) funding projects that integrate medical imaging with fluid-based (liquid biopsy) tumor monitoring during cancer therapy. Eligible applicants are domestic institutions such as universities, tribal governments, and community-based organizations; foreign organizations and foreign components are not eligible. The award is capped at about $500,000. This is an oncology research mechanism aimed at research institutions, not individuals or general nonprofits.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreLimited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
A limited-competition NIH planning grant (R34, clinical trial not allowed) supporting fundamental research on skin injuries caused by chemical threats and potential shared therapeutic targets. Eligible applicants are domestic institutions such as universities, tribal governments, and community-based organizations; foreign organizations and foreign components of U.S. organizations are not eligible, though foreign components within the project are allowed. No specific award amount is stated. As a limited competition, eligibility may be further restricted beyond the listed categories, so review the NOFO closely.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreLaboratories to Optimize Digital Health (R01 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIMH (R01) opportunity funds research testing strategies to increase the reach, efficiency, and effectiveness of digital mental health interventions, including clinical trials on established platforms. A clinical trial is required. It targets research and academic institutions rather than individuals or general nonprofits/small businesses; no specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIDCR (R03) small-grant program supports pilot or feasibility studies in oral, dental, and craniofacial research by scientists early in establishing an independent research career. It is intended for new-investigator researchers at eligible institutions; foreign organizations are not eligible to apply. No specific award amount is stated, though R03 awards are typically modest.
ResearchersSchools & universitiesNew orgs OKNarrow eligibilityModular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity supports investigator-initiated research in cancer control and population sciences, including epidemiology, survivorship, behavioral interventions, and health-data science. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is given.
ResearchersSchools & universitiesNarrow eligibilityClinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity funds collaborative research on chronic or delayed adverse effects of cancer therapies and mechanism-based interventions to prevent or reduce them. It is aimed at research and academic institutions, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNeuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R21 funds development of next-generation brain stimulation devices for mental health disorders, either wholly new stimulation approaches or significant upgrades to FDA-cleared devices. Applicants should be multidisciplinary research teams spanning neuroscience, engineering, and regulatory expertise at eligible research institutions. No award amount is specified, and incremental software updates alone don't qualify.
ResearchersNarrow eligibility